Skip to search.
 TSX Down 0.01% TSX Ventures Up 0.16%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
17.47 Up 0.21(1.22%) 11:28AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:17.26
Open:17.21
Bid:17.48 x 500
Ask:17.55 x 600
1y Target Est:33.00
Beta:1
Earnings Date:May 6 - May 11 (Est.)
Day's Range:17.13 - 17.59
52wk Range:5.40 - 25.60
Volume:79,367
Avg Vol (3m):689,133
Market Cap:882.51M
P/E (ttm):N/A
EPS (ttm):-1.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):113.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.07
Quarterly EPS Est (Mar-15) :-0.26
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback